Two fluorescence modes were combined to analyze the binding properties of terminally substituted alkanes (CnX, X = COOH, OH, CHO, NH2) to human serum albumin (HSA). A competitive binding assay using an 8-anilino-1-naphthalenesulfonate (ANS) fluorescence probe provides information on all the hydrophobic binding sites in HSA. A binding assay using the intrinsic fluorescence of the tryptophan residue in HSA (Trp-HSA) provides information on the specific binding site close to the tryptophan residue. There are three fluorescence-active ANS binding sites in HSA, which can be classified into two types by their affinity for ANS. CnCOOH bound to all three ANS binding sites including the Trp-HSA site, however, it did not quench the fluorescence of Trp-HSA. CnCHO bound only to the Trp-HSA site with quenching of the fluorescence of Trp-HSA. By comparing the binding affinities of HSA for CnOH and CnCHO, it was concluded that the CnOH binding site is different from the CnCHO binding site. CnNH2 did not bind to any of the three ANS binding sites in HSA.
Introduction
Small hydrophobic drugs such as general anesthetics have been considered to bind to both the lipid bilayer and membrane proteins of cells. [1] [2] [3] [4] However, details of the action mechanisms of these drugs still remain unclear. To study the binding properties of hydrophobic molecules to proteins, a fluorometric titration using 8-anilino-1-naphthalenesulfonate (ANS) is a popular method because of its unique fluorescence characteristics. 5 ANS fluoresces strongly in a hydrophobic environment, though it scarcely fluoresces in water, therefore, the change in the fluorescence intensity of ANS is a very sensitive indicator for the transfer of ANS from the bulk aqueous solution to the hydrophobic binding sites in protein. Competitive binding analysis using the fluorescence of ANS provides useful information on the binding properties of a target species. 6 The binding of hydrophobic molecules or ions to bovine serum albumin (BSA) and to human serum albumin (HSA) has been extensively studied for many years. [7] [8] [9] [10] Serum albumins are the most predominant proteins in blood plasma and have been known to act as the transporter of various biologically active species including drugs. 11, 12 ANS has been frequently used to study the binding properties of hydrophobic species to albumins. 13 On the other hand, the intrinsic fluorescence of the tryptophan (Trp) and tyrosine (Tyr) residues in albumin have also been used as probes in binding analyses. [14] [15] [16] HSA has only one Trp residue in the sub-domain IIA region, which has been considered to be the major drug-binding site of HSA. 17, 18 Therefore, the fluorescence of the Trp in HSA (Trp-HSA) is a useful probe for the binding to this site. Although the fluorescences of ANS and Trp-HSA have been widely used for the binding studies of biological molecules to HSA, the information available from these fluorescences is different. The fluorescence of Trp-HSA provides direct information specific to this site, in contrast, the fluorescence of ANS provides information on all the hydrophobic binding sites in HSA. Moreover, the binding species of interest are expected to show different quenching properties for the fluorescences of ANS and Trp-HSA. 19 In our previous studies, we demonstrated that terminallysubstituted alkanes (CnX) are useful model agents for studying the binding properties of biologically active hydrophobic agents on proteins, because the hydrophobicity and charge of CnX can be controlled by the alkyl-chain length (n) and the terminal unit (X), respectively. 20, 21 In the present study, we examined the effects of CnX (X = OH, COOH, CHO and NH2) on the fluorescence intensity of the ANS bound to HSA. We also examined the effect of CnX on the fluorescence intensity of Trp-HSA. The fluorescence quenching of the ANS by CnX can be attributed to the release of the ANS from the hydrophobic binding sites in HSA by the competitive binding of CnX. In contrast, we have found that the binding of CnX to the Trp-HSA site does not necessarily result in the quenching of the Trp-HSA fluorescence. The comparative analysis of the ANS and Trp-HSA fluorescences provides information on the binding behavior of CnX to HSA that cannot be obtained by either of these measurements alone. 
Experimental

Materials and sample preparation
Essentially fatty-acid-free human serum albumin (Cat. No. A1887), glycylglycine and L-tryptophan were purchased from Sigma Chemical Co. and used without further purification. 8-Anilino-1-naphthalenesulfonic acid sodium salt (ANS·Na) was purchased from Tokyo Chemical Industry Co. Terminally substituted alkane analogues were purchased from Sigma Chemical Co., Tokyo Chemical Industry Co., Aldrich Chemical Co. or Across Organics and were used as supplied. All sample solutions were prepared using water purified by a Milli-Q-SP reagent water system. Stock solutions of 50 mmol dm -3 HSA and 10 mmol dm -3 ANS were prepared by dissolving HSA and ANS·Na, respectively, into purified water containing 0.1 mol dm -3 glycylglycine buffer of pH 7.4. The concentration of HSA was determined by UV/VIS absorbance using the molar absorption coefficient 3.58 ¥ 10 4 cm -1 mol -1 dm 3 at 280 nm and the molecular weight 6.65 ¥ 10
4
. The concentration of ANS was also determined by UV/VIS absorbance using the molar absorption coefficient 5.83 ¥ 10 3 cm -1 mol -1 dm 3 at 350 nm. The absorption spectra were measured with a Shimadzu RF-2200 UV/VIS double-beam spectrophotometer.
The HSA solution saturated with bound ANS (ANS-HSA) was prepared by mixing the HSA and ANS solutions with their final concentrations of 1.0 and 10 mmol dm -3 , respectively. The pH of all sample solutions was adjusted to 7.4 with 0.1 mol dm -3 glycylglycine buffer.
Fluorescence measurements
The molar fluorescence intensity of the ANS bound to HSA was obtained by the fluorometric titration of ANS with HSA as follows. The fluorescence intensity of ANS was measured by changing the HSA concentration while maintaining the ANS concentration constant at 35 mmol dm -3 . The observed fluorescence intensity was then extrapolated to infinite HSA concentration. The molar fluorescence intensity of the ANS bound to HSA was finally obtained as the fluorescence intensity at infinite HSA concentration divided by the ANS concentration.
The number of ANS binding sites in HSA (nsite) and the binding constants of ANS to HSA (Kbind) were obtained by the fluorometric titration of HSA solution with ANS by the following procedure. The fluorescence intensity of ANS was measured by changing the ANS concentration while maintaining the HSA concentration constant at 1.0 mmol dm -3 . The observed fluorescence intensity was then converted to the number of ANS ions bound to an HSA molecule (nbind) using the molar fluorescence intensity of the ANS bound to HSA. To obtain the nsite and Kbind values, the nbind value and the concentration of bound-free ANS, [ANS]free, were analyzed by a Scatchard plot.
To estimate the effects of CnX on the binding behavior of ANS to HSA, ANS-HSA solution 2.97 cm 3 was titrated with an appropriate concentration of 0.03 cm 3 CnX methanol solution. It was confirmed that this methanol concentration does not affect the fluorescence intensity of ANS-HSA. The bound fraction of CnX, q (= nbind/nsite), and the binding affinity were estimated by the nonlinear least squares curve-fitting for the plot of the CnX concentration versus the fluorescence intensity of ANS by assuming the Langmuir binding isotherm. Origin 7.0 software (Origin Lab) was used for the nonlinear least squares curvefitting analysis.
To estimate the effects of CnX and ANS on the fluorescence intensity of Trp-HSA, 5.0 mmol dm -3 of HSA solution 2.97 cm 3 was titrated with 0.03 cm 3 CnX or ANS solution. The effect of the competitive binding of CnX and ANS on the fluorescence intensity of Trp-HSA was also examined by titrating the ANS-HSA solution with CnX by recording the fluorescence intensities of ANS and Trp-HSA. The fluorescence intensity was measured with a Hitachi 650-60 fluorescence spectrophotometer equipped with a temperaturecontrolled cell holder. The slit widths of excitation and emission were set at 5 nm. The cell temperature was controlled at 25 ± 0.2˚C using an NESLAB RTE-9 circulation water bath. The fluorescence intensity of ANS was measured with an excitation wavelength of 373 nm. The emission spectra of ANS were recorded between 465 and 485 nm, and the peak wavelengths were observed at around 474 nm. The fluorescence intensity of the Trp-HSA was measured with an excitation wavelength of 295 nm. Although the peak wavelength of the excitation spectrum was observed at 280 nm, 295 nm was chosen to eliminate the effect of the tyrosine residues. The emission spectra of Trp-HSA were recorded between 335 and 355 nm, and the peak wavelengths were observed at around 344 nm. For the fluorescence measurements, sample solutions were mixed in a 1-cm path length fluorescence cell having a Teflon ® stopper and allowed to stand for more than 15 min in the temperaturecontrolled cell holder to equilibrate the binding reaction.
Calculation of electronic energy
The LUMO energies of the Trp-HSA, ANS and C8Xs were estimated using the B3LYP/6-311G+g(d,p) functional and basis set incorporated in the Gaussian 03 software package (Rev. D.01). 22 N-Acetyl-D-tryptophan methyl ester (ATrpM) was used as the model substance of the Trp-HSA.
Results and Discussion
Binding of ANS to HSA Figure 1 shows the Scatchard plot of the binding of ANS to HSA created by using the fluorometric titration of HSA with ANS. The curved plot indicates the presence of the different types of ANS binding sites in HSA. The plot was analyzed by assuming the Langmuir binding isotherm for two different types, type-1 and type-2, of the binding sites in HSA. As shown by the dotted line in Fig. 1 , the plot was well fitted with the maximum binding numbers of nmax(1) = 0.82 and nmax(2) = 2.0 and the corresponding binding constants of Kbind(1) = 6.3 ¥ 10 6 mol -1 dm 3 and Kbind(2) = 7.1 ¥ 10 5 mol -1 dm 3 for the type-1 and type-2 sites, respectively. These values are in good agreement with the values reported by several authors. [23] [24] [25] [26] Based on the nmax(1) and nmax (2) values thus obtained, we concluded that there are three fluorescence-active ANS binding sites, nsite = 3, in HSA. We previously reported the binding behavior of ANS to BSA, in which identical affinity for four ANS binding sites are expected by the Scatchard analysis. 21 The binding properties of the HSA and BSA have been frequently discussed on the assumption of their structural similarities because the three-dimensional structure was determined only for HSA. 27 However, attention should be paid to the small differences in their structures in discussing the correlation between structure and binding properties. 10, 28, 29 Binding of CnX to HSA Figure 2 shows the effects of CnX on the fluorescence intensity of ANS-HSA solution, in which the fluorescence intensity was plotted as a function of the total concentration of CnX, [CnX]total.
The relative fluorescence intensity was obtained as the fluorescence intensity of the ANS-HSA solution in the presence of CnX relative to the intensity in the absence of CnX. C9COOH almost entirely quenched the fluorescence of ANS-HSA with an inflection point at the C9COOH concentration of about 10 mmol dm -3 . C9CHO and C10OH quenched about 50 and 20%, respectively, of the initial fluorescence at their maximum soluble concentrations. In contrast, C10NH2 did not quench the fluorescence at all. As already indicated by the binding assay of ANS to HSA, this result also supports the presence of the two different types of binding sites in HSA. CnCOOH replaced all the ANS ions bound to the HSA, however, CnCHO and CnOH replaced only the ANS bound to either one of the two types of sites.
In the cases of CnCOOH, CnCHO and CnOH, the decrease in the fluorescence intensity can be converted to the bound fraction of CnX (q) with the assumption that the decrease in the fluorescence intensity is a direct consequence of the release of ANS from the binding site in HSA by the competitive binding of CnX. These results will indicate that the independence of each binding site in HSA, assumed for the binding of ANS, does not hold for the competitive binding of CnX with ANS-HSA. The binding of one CnX to the HSA site may cause a small change in the HSA conformation, followed by a change in the affinity of the remaining HSA sites for ANS. If the binding of CnX decreases the affinity for the remaining sites, the competitive binding of one CnX triggers an additional release of the ANS from HSA. With the increase in the alkylchain length of CnX, a larger conformational change in HSA is expected when it binds to HSA. The observed increase in the q values with the alkyl-chain length of CnX can then be attributed to this effect. Figure 6 shows the change in the fluorescence intensities of ANS and Trp-HSA when the HSA solution was titrated with ANS. The fluorescence intensity of ANS increased with the ANS concentration, but the fluorescence intensity of Trp-HSA decreased with the ANS concentration. These results indicate that one of the three ANS binding sites is close to the Trp-HSA and that the ANS bound to this site quenches the fluorescence of Trp-HSA. As shown in Fig. 6 , the ANS decreased more than 60% of the initial fluorescence intensity of Trp-HSA at a concentration equal to that of HSA. This result means that the ANS binds most preferentially to the Trp-HSA site compared to other two sites in HSA. Therefore, we can assign the Trp-HSA site as a type-1 site that has a higher affinity for ANS. This site assignment is supported by the study of Yang et al., 30 in which salicylic acid was found to bind preferentially to the sub-domain IIA of HSA. Salicylic acid has an aromatic fragment similar to that of ANS and Trp-HSA is located in the sub-domain IIA. Figure 7 shows the effects of C8X on the fluorescence intensity of Trp-HSA. The C8CHO decreased the fluorescence of Trp-HSA, however, C8COOH, C8OH and C8NH2 did not decrease the fluorescence of Trp-HSA at all. In the competitive binding assay of C8CHO with ANS-HSA, it decreased about 38% of the initial intensity of ANS-HSA fluorescence.
Effect of ANS and CnX on the fluorescence of Trp-HSA
This value corresponds to the release of one ANS among the total three bound to HSA. It can be concluded from these results that, under the present condition, CnCHO binds only to the type-1 Trp-HSA site.
As shown in Fig. 2 , CnCOOH binds to all the ANS binding sites in HSA including the Trp-HSA site. Despite this, CnCOOH CnNH2 quenched neither the ANS-HSA fluorescence nor the Trp-HSA fluorescence, indicating that it does not bind to the ANS binding sites in HSA. However, CnNH2 has been known to bind to polypeptide chains with non-specific interactions and to promote a conformational change in proteins. 31 As shown in Fig.  2 , the increase in the ANS fluorescence at the higher concentration of CnNH2 can be attributed to the partial conformational change in HSA, caused by the nonspecific binding of CnNH2, to expose the inner hydrophobic parts of the HSA.
It remains unclear why CnCOOH and CnCHO behave in different ways in the quenching of the Trp-HSA fluorescence even though they bind to the same Trp-HSA site. To gain insight on this problem, the electronic energies of Trp, ANS and C8X were calculated using the Gaussian 03 program package. The estimated LUMO energy levels of ANS -(-1.598 eV) and C8CHO (-1.306 eV) are lower than that of Trp (-0.764 eV), indicating the possible energy transfer from the excited state of Trp to ANS -and C8CHO. In contrast, the LUMO energy levels of C8COO -(0.304 eV), C8OH (0.253 eV) and C8NH3 + (-0.324 eV) are higher than that of Trp, and therefore, the energy transfer from the excited state of Trp to these species is not expected. The different quenching behavior between CnCHO and CnCOOH for Trp-HSA fluorescence can then be attributed to the difference in the LUMO energy levels of these species.
Conclusions
In the present study, we demonstrated the availability of the complimentary analysis of two fluorescence measurements for the binding assay of hydrophobic molecules to protein. The binding assay using the fluorescence of an ANS probe provides information on all the hydrophobic binding sites. On the other hand, the binding assay using the intrinsic fluorescence of Trp-HSA provides information specific to this site.
ANS binds to the three hydrophobic binding sites in HSA including the Trp-HSA site with quenching of the fluorescence of Trp-HSA. CnCOOH also binds to these three sites in competition with ANS, however, it does not quench the fluorescence of Trp-HSA. CnCHO binds only to the Trp-HSA site with quenching of the fluorescence of Trp-HSA. In contrast, CnOH is suggested to bind to the site not to the Trp-HSA from a comparison of the IC50 values among CnCOOH, CnCHO and CnOH. CnNH2 did not quench the fluorescence of the ANS bound to HSA at all, indicating the lower affinity for all three ANS binding sites.
In conclusion in this study, we demonstrated the availability of the use of two fluorescence modes to assign the binding sites of hydrophobic molecules in protein. The binding sites of CnX in HSA could be assigned using the fluorescence of an ANS probe and the intrinsic fluorescence of the Trp-HSA.
